Title:
エナンチオマー的に純粋なβ‐D‐ジオキソラン-ヌクレオシド
Document Type and Number:
Japanese Patent JP4503206
Kind Code:
B2
Abstract:
A method and composition for the treatment of humans infected with HIV that includes administration of an HIV treatment amount of an enantiomerically pure beta -D-dioxolanyl purine nucleoside of formula (I), wherein R is OH, Cl, NH2, or H, or a pharmaceutically acceptable salt or derivative of the compound, optionally in a pharmaceutically acceptable carrier or diluent.
Inventors:
Chang Kai Chu
Raymond F Synergy
Raymond F Synergy
Application Number:
JP2001251947A
Publication Date:
July 14, 2010
Filing Date:
August 22, 2001
Export Citation:
Assignee:
University of Georgia Research Foundation Incorporated
Emory University
Emory University
International Classes:
A61K31/52; C07D473/18; A61K31/505; A61K31/506; A61K31/513; A61K31/522; A61K31/53; A61K31/675; A61K31/7076; A61K38/21; A61P31/12; A61P31/18; A61P37/04; C07D327/04; C07D405/04; C07D411/04; C07D473/00; C07D473/16; C07D473/30; C07D473/34; C07D473/40; C07D497/08; C07F9/6561
Domestic Patent References:
| JP1316375A |
Foreign References:
| WO1992010497A1 |
Attorney, Agent or Firm:
Yoshio Kawaguchi
Makoto Ono
Chihiro Watanabe
Kenkyo Kanayama
Katsuma Osaki
Mitsuaki Tsubokura
Makoto Ono
Chihiro Watanabe
Kenkyo Kanayama
Katsuma Osaki
Mitsuaki Tsubokura